US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Bio Essence Corporation (QB) (BIOE) 銘柄情報

Bio Essence Corporation (QB) (BIOE)

0.2703

0.00

(0.00%)

終了 7月13日 5:00AM

Bio Essence Corporation (QB) (BIOE) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.2703

( - )

買値

0.161

売値

0.55

出来高

-

平均取引量 (3 か月)

US$ 6,938

財務取引量

-

0.00 日の範囲 0.00

0.051 52 週間の範囲 0.517

時価総額

企業価値

16.074M

前日終値

0.2703

始値

-

時刻

最終取引時間

VWAP

-

歳入

2.38M

純利益

1.31M

発行済株式数

53,809,000

浮動株比率 (%)

36.08%

機関投資家保有比率 (%)

-

配当利回り

PER

8.22

株価売上高倍率 (PSR)

6.12

1 株当たり利益 (EPS)

0.03

ベータ

11.37

Bio Essence Corporation engages in manufacturing and distributing health supplement products. It also offers original equipment manufacturing, and private label services for dietary supplements, vitamins, and herbal nutrition products. Bio Essence Corporation was incorporated in 2000 and is headquar... Bio Essence Corporation engages in manufacturing and distributing health supplement products. It also offers original equipment manufacturing, and private label services for dietary supplements, vitamins, and herbal nutrition products. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.bioessencecorp.com

本社

Irvine, United States

設立

2026

Bio Essence Corporation (QB) is listed in the sector of the その他OTC with ticker BIOE. The last closing price for Bio Essence (QB) was US$0.27. Over the last year, Bio Essence (QB) shares have traded in a share price range of US$ 0.051 to US$ 0.517.

Bio Essence (QB) currently has 53,809,000 shares in issue. The market capitalisation of Bio Essence (QB) is US$14.54 million. Bio Essence (QB) has a price to earnings ratio (PE ratio) of 8.22.

Form 8-K/A - Current report: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio

Global AI in Fitness and Wellness Market Size was valued at USD 10.68 Billion in 2025 and is predicted to reach USD 57.80 Billion by the year 2035...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

BIO ESSENCE CORP (OTCQB:BIOE) Announces Approval for Upgrade to the OTCQB Market, Effective February 26, 2026

The company's approval to upgrade to the OTCQB Venture Market underscores a growing trend among international, growth-stage companies to expand...

BIO ESSENCE CORP (OTC Pink: BIOE) Announces Commencement of Regulation A Tier 2 Offering for up to $5.0 Million

Management Plans To Take Advantage Of Projected Growth In The AI In Healthcare Market Which Is Projected To Reach USD 505.59 Billion By 2033...

Form QUALIF - Notice of Qualification [Regulation A]

Form 1-A - Offering Statement [Regulation A]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0.0178	7.0495049505	0.2525	0.2703	0.1819	8881	0.1868772	CS
12	-0.1297	-32.425	0.4	0.517	0.1819	5288	0.35148679	CS
26	0.2123	366.034482759	0.058	0.517	0.051	11225	0.15888875	CS
52	0.1606	146.399270738	0.1097	0.517	0.051	6865	0.14240112	CS
156	0.0103	3.96153846154	0.26	10.808543	0.051	29897	2.60525016	CS
260	-0.2297	-45.94	0.5	10.808543	0.051	27992	2.59817237	CS

BIOE - Frequently Asked Questions (FAQ)

What is the current Bio Essence Corporation (QB) share price?

The current share price of Bio Essence Corporation (QB) is US$ 0.2703

How many Bio Essence Corporation (QB) shares are in issue?

Bio Essence Corporation (QB) has 53,809,000 shares in issue

What is the market cap of Bio Essence Corporation (QB)?

The market capitalisation of Bio Essence Corporation (QB) is USD 14.54M

What is the 1 year trading range for Bio Essence Corporation (QB) share price?

Bio Essence Corporation (QB) has traded in the range of US$ 0.051 to US$ 0.517 during the past year

What is the PE ratio of Bio Essence Corporation (QB)?

The price to earnings ratio of Bio Essence Corporation (QB) is 8.22

What is the cash to sales ratio of Bio Essence Corporation (QB)?

The cash to sales ratio of Bio Essence Corporation (QB) is 6.12

What is the registered address of Bio Essence Corporation (QB)?

The registered address for Bio Essence Corporation (QB) is 2955 Main Street, Irvine, California, 92618

What is the Bio Essence Corporation (QB) website address?

The website address for Bio Essence Corporation (QB) is www.bioessencecorp.com

surfer44

surfer44 2分前

World's first: China recovers rocket booster with net system at sea #coolchina

https://youtu.be/2D_GstQJp0U

goodietime

goodietime 3分前

"they have to follow absolute priority as per law IMO.'

UMM, NO.

That would have been the law, EXCEPT.....

ALL Documents and Prospectuses for Prefs and Common were CANCELLED.

They are NOW Equity Interests. THEREFORE, there is no absolute p

100lbStriper

100lbStriper 3分前

need more chips and nlst tec...... https://www.cnbc.com/amp/2026/07/10/sk-hynix-skhy-stock-nasdaq.html

Naught

NF

299B is pure garbage..
WMI remaining estate assets worth in the trillions...

DruidMarauder68

DruidMarauder68 4分前

Remember, it's a long game, patience and acquisition at rthese low prices is what we do now.

Eli's Gone

Eli's Gone 4分前

Didn't pick him but I'm rootin' for Ricky....

bobby1151

bobby1151 8分前

After looking at your alias date 2009 U R a long-term BIELER (like Bobby) & soon we should C COPPER per Billionaire's posts!!!!!!!

bobby1151

bobby1151 8分前

After looking at your alias date 2009 U R a long-term BIELER (like Bobby) & soon we should C COPPER per Billionaire's posts!!!!!!!

nowwhat2

nowwhat2 8分前

Explosive growth going forward.

☺️

Future global leader.

.

capgain

capgain 11分前

Thanks, you too.

Royal Dude

Royal Dude 12分前

Amen Newflow Let the info flow

TradingCharts

TradingCharts 13分前

https://media.stocktwits-cdn.com/api/3/media/13454091/default.webp
https://www.linkedin.com/posts/david-dong-myung-kim-8a05b5130_ultium-cells-our-joint-venture-with-general-share-7480503981115600897-nYJo/?utm_source=share&utm_medium=member_desktop&rcm=ACoAACqICfIBDnVCtKiuX6gsoBWZSJ9pAt341yg

cowtown jay

cowtown jay 13分前

Eli's Gone

Eli's Gone 14分前

Eli's Gone

Eli's Gone 15分前

Eli's Gone

Eli's Gone 15分前

12yearplan

12yearplan 17分前

$FOBIF $FOBI

https://www.reddit.com/media?url=https%3A%2F%2Fpreview.redd.it%2Fzj49ybbslhch1.jpeg%3Fwidth%3D1080%26crop%3Dsmart%26auto%3Dwebp%26s%3D859bfc08e1b92368f228b237aa63ed4201faffec

NotTheRealBeeny

NotTheRealBeeny 20分前

I tend to agree.

It seems there is a fresh supply of fools every minute, as someone once said.

Squeeze chasers, pump groups all playing with fire. Some deserve it.

capgain

capgain 23分前

pqr

And if the eventual availability of the patient-based data was known (as is likely) in 2025 or even possibly 2024 this likely explains the delay at MHRA. And certainly would seem to bode well for other approvals.

shadolane

shadolane 29分前

Thank you Bobby and Serious for your cordial comments.

It's refreshing to have respectful dialogue.

Bio Essence (QB)

Hedge Brasil Log Indust ...

Harvest US Bank Leaders ...

Jpmorgan Chase Financial...

DJ International Interne...

CRSP US Small Mid Cap Gr...

Euronext European Sovere...

August Equity Fund Iii

Optimix Incom Fd C

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。